Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification

Tissue Engineering - Part C: Methods

Volumn 18, Issue 4, 2012, Pages 283-292

  Helmrich, Uta ^a   Marsano, Anna ^a   Melly, Ludovic ^a   Wolff, Thomas ^a   Christ, Liliane ^a   Heberer, Michael ^a   Scherberich, Arnaud ^a   Martin, Ivan ^a   Banfi, Andrea ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; CELL MEMBRANES; EXPANSION; FLOW CYTOMETRY; FLOWCHARTING; OPTIMIZATION; RATS; TISSUE; TISSUE ENGINEERING;

ADIPOSE TISSUE; ANGIOGENIC FACTOR; ATTRACTIVE STRATEGIES; BONE MARROW; CELL SURFACE MARKER; FIRST-PASSAGE; GENETICALLY MODIFIED; IN-VITRO; OVER-EXPRESSION; REGENERATIVE MEDICINE; RETROVIRAL TRANSDUCTION; RETROVIRAL VECTORS; STROMAL CELLS; THERAPEUTIC APPLICATION; THERAPEUTIC TRANSGENE; TIME POINTS; TRANSGENE EXPRESSION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

CELL CULTURE;

RATTUS;

BIOLOGICAL MARKER; VASCULOTROPIN A;

ADULT; ADULT STEM CELL; ANIMAL; ARTICLE; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MOUSE; RAT; RETROVIRUS; TRANSGENE;

ADULT; ADULT STEM CELLS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; MESENCHYMAL STEM CELLS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; RATS; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859043478     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2011.0413     Document Type: Article

References (38)

1. Satija, N.K., Singh, V.K., Verma, Y.K., Gupta, P., Sharma, S., Afrin, F., et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med 13, 4385, 2009.
2. Kumar, S., Chanda, D., and Ponnazhagan, S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 15, 711, 2008.
3. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
4. Helder, M.N., Knippenberg, M., Klein-Nulend, J., and Wuisman, P. Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng 13, 1799, 2007.
5. Salem, H.K., and Thiemermann, C. Mesenchymal Stromal Cells: current understanding and clinical status. Stem Cells 28, 585, 2010.
6. Kneser, U., Stangenberg, L., Ohnolz, J., Buettner, O., Stern-Straeter, J., Mobest, A., et al. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med 10, 695, 2006.
7. Scheufler, O., Schaefer, D.J., Jaquiery, C., Braccini, A., Wendt, D.J., Gasser, J.A., et al. Spatial and temporal patterns of bone formation in ectopically pre-fabricated, autologous cell-based engineered bone flaps in rabbits. J Cell Mol Med 12, 1238, 2008.
8. Scherberich, A., Muller, A.M., Schafer, D.J., Banfi, A., and Martin, I. Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts. J Cell Physiol 225, 348, 2010.
9. Carmeliet, P. Angiogenesis in health and disease. Nature Med 9, 653, 2003.
10. Banfi, A., von Degenfeld, G., Blau, H.M. Critical role of microenvironmental factors in angiogenesis. Curr Atheroscler Rep 7, 227, 2005.
11. Ozawa, C.R., Banfi, A., Glazer, N.L., Thurston, G., Springer, M.L., Kraft, P.E., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113, 516, 2004.
12. Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G.I., Carmeliet, P., et al. Conditional switching of VEGF provides new insights into adult neovascularization and proangiogenic therapy. EMBO J 21, 1939, 2002.
13. Sheridan, C. Gene therapy finds its niche. Nature Biotechnol 29, 121, 2011.
14. Zhang, X.J., Godbey, W.T. Viral vectors for gene delivery in tissue engineering. Adv Drug Deliv Rev 58, 515, 2006.
15. Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., and Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28, 707, 2000.
16. DiGirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107, 275, 1999.
17. Scherberich, A., Galli, R., Jaquiery, C., Farhadi, J., and Martin, I. Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells 25, 1823, 2007.
18. Horn, P., Bork, S., Diehlmann, A., Walenda, T., Eckstein, V., Ho, A.D., et al. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy 10, 676, 2008.
19. Mueller, A.M., Davenport, M., Verrier, S., Droeser, R., Alini, M., Bocelli-Tyndall, C., et al. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A 15, 869, 2009.
20. Banfi, A., Springer, M.L., Blau, H.M. Myoblast-mediated gene transfer for therapeutic angiogenesis. Gene Ther Methods 346, 145, 2002.
21. Cifone, M.G., Migliorati, G., Parroni, R., Marchetti, C., Millimaggi, D., Santoni, A., et al. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93, 2282, 1999.
22. Watson, J.V., Chambers, S.H., and Smith, P.J. A pragmatic approach to the analysis of dna histograms with a definable g1 peak. Cytometry 8, 1, 1987.
23. Wolff, T., Mujagic, E., Gianni-Barrera, R., Fueglistaler, P., Helmrich, U., Misteli, H., et al. FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia. J Cell Mol Med 2011 [Epub ahead of print]; DOI: 10.1111/j.1582-4934.2011.01308.x.
24. Springer, M.L., and Blau, H.M. High-efficiency retroviral infection of primary myoblasts. Somat Cell Mol Genet 23, 203, 1997.
25. Frank, O., Heim, M., Jakob, M., Barbero, A., Schafer, D., Bendik, I., et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 85, 737, 2002.
26. Martin, I., Jakob, M., Schafer, D., Dick, W., Spagnoli, G., and Heberer, M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9, 112, 2001.
27. Mizuguchi, H., Xu, Z.L., Ishii-Watabe, A., Uchida, E., and Hayakawa, T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1, 376, 2000.
28. de la Serna, I.L., Ohkawa, Y., and Imbalzano, A.N. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nature Rev Genet 7, 461, 2006.
29. Misteli, H., Wolff, T., Fü glistaler, P., Gianni-Barrera, R., Gü rke, L., Heberer, M., et al. High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo. Stem Cells 28, 611, 2010.
30. Conn, G., Soderman, D.D., Schaeffer, M.T., Wile, M., Hatcher, V.B., and Thomas, K.A. Purification of a glycoprotein vascular endothelial-cell mitogen from a rat gliomaderived cell-line. Proc Natl Acad Sci USA 87, 1323, 1990.
31. Marx, J.C., Allay, J.A., Persons, D.A., Nooner, S.A., Hargrove, P.W., Kelly, P.F., et al. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. Hum Gene Ther 10, 1163, 1999.
32. Li, H.X., Zuo, S., He, Z.S., Yang, Y.T., Pasha, Z., Wang, Y.G., et al. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. Am J Physiol Heart Circ Physiol 299, H1772, 2010.
33. Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L.N., Solomon, S.D., Deb, A., et al. Mesenchymal stem cells overexpressing akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14, 840, 2006.
34. Wolbank, S., Stadler, G., Peterbauer, A., Gillich, A., Karbiener, M., Streubel, B., et al. Telomerase immortalized human amnion-and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. Tissue Eng Part A 15, 1843, 2009.
35. Liu, X.D., Constantinescu, S.N., Sun, Y., Bogan, J.S., Hirsch, D., Weinberg, R.A., et al. Generation of mammalian cells stably expressing multiple genes at predetermined levels. Anal Biochem 280, 20, 2000.
36. Yla-Herttuala, S., Rissanen, T.T., Vajanto, I., and Hartikainen, J. Vascular endothelial growth factors-Biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49, 1015, 2007.
37. Rouwkema, J., Rivron, N.C., and van Blitterswijk, C.A. Vascularization in tissue engineering. Trends Biotechnol 26, 434, 2008.
38. von Degenfeld, G., Banfi, A., Springer, M.L., Wagner, R.A., Jacobi, J., Ozawa, C.R., et al. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. Faseb J 20, 2657, 2006.